CCCC
Price
$1.36
Change
-$0.13 (-8.67%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
106.51M
84 days until earnings call
CRVS
Price
$3.63
Change
-$0.26 (-6.68%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
299.98M
90 days until earnings call
Ad is loading...

CCCC vs CRVS

Header iconCCCC vs CRVS Comparison
Open Charts CCCC vs CRVSBanner chart's image
C4 Therapeutics
Price$1.36
Change-$0.13 (-8.67%)
Volume$5.46K
Capitalization106.51M
Corvus Pharmaceuticals
Price$3.63
Change-$0.26 (-6.68%)
Volume$6.93K
Capitalization299.98M
CCCC vs CRVS Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. CRVS commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and CRVS is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (CCCC: $1.50 vs. CRVS: $3.89)
Brand notoriety: CCCC and CRVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 87% vs. CRVS: 77%
Market capitalization -- CCCC: $106.51M vs. CRVS: $299.98M
CCCC [@Biotechnology] is valued at $106.51M. CRVS’s [@Biotechnology] market capitalization is $299.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileCRVS’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • CRVS’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than CRVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 5 TA indicator(s) are bullish while CRVS’s TA Score has 5 bullish TA indicator(s).

  • CCCC’s TA Score: 5 bullish, 3 bearish.
  • CRVS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than CRVS.

Price Growth

CCCC (@Biotechnology) experienced а +6.38% price change this week, while CRVS (@Biotechnology) price change was +16.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.95%. For the same industry, the average monthly price growth was +6.81%, and the average quarterly price growth was -5.99%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

CRVS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+0.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRVS($300M) has a higher market cap than CCCC($107M). CRVS YTD gains are higher at: -27.290 vs. CCCC (-58.333). CRVS has higher annual earnings (EBITDA): -25M vs. CCCC (-103.37M). CCCC has more cash in the bank: 245M vs. CRVS (41.7M). CRVS has less debt than CCCC: CRVS (354K) vs CCCC (65.8M). CCCC has higher revenues than CRVS: CCCC (35.6M) vs CRVS (0).
CCCCCRVSCCCC / CRVS
Capitalization107M300M36%
EBITDA-103.37M-25M413%
Gain YTD-58.333-27.290214%
P/E RatioN/AN/A-
Revenue35.6M0-
Total Cash245M41.7M588%
Total Debt65.8M354K18,588%
FUNDAMENTALS RATINGS
CRVS: Fundamental Ratings
CRVS
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCCRVS
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-5.06%
KYMR - CCCC
64%
Loosely correlated
-3.20%
CRBU - CCCC
56%
Loosely correlated
-4.31%
BEAM - CCCC
54%
Loosely correlated
-1.04%
PRME - CCCC
52%
Loosely correlated
-5.22%
NTLA - CCCC
52%
Loosely correlated
-2.69%
More

CRVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been loosely correlated with SYRE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVS jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
-4.07%
SYRE - CRVS
37%
Loosely correlated
-1.21%
DNLI - CRVS
33%
Loosely correlated
-3.65%
VKTX - CRVS
33%
Poorly correlated
-2.00%
CCCC - CRVS
33%
Poorly correlated
-5.06%
KYMR - CRVS
32%
Poorly correlated
-3.20%
More